Posted on: March 26, 2018, by : sumedho


Wednesday, 18 July 2018, RS Penyakit Infeksi Prof. Dr. Sulianti Saroso


  1. To increase the awareness of amr problem
  2. To increase the rational use if antibiotics
  3. To increase the use of microbiology examination and its clinical implementation


Target audiences:

Clinicians, PPRA RS Team



07.30 – 08.00


08.00 – 08.15

AMR Situation and Control in South East Asia Region of WHO
Tjandra Yoga Aditama (Senior Advisor, WHO SEARO)

08.15 – 08.30

Keynote Speech and Opening Remarks
Bambang Wibowo (Directorate General of Health Services – INA)

08.30 –08.45

Introduction and Pre Test
Dewi Anggraini (INA)

08.45 – 09.15

Global Problem of Antimicrobial Resistance (AMR)
Hari Parathon (Chairman of AMR Control Comittee, MoH – INA)
AMR situation in the world
Strategies to prevent the end the antibiotic era

09.15 – 09.45

Antimicrobial Resistance Control Program (PPRA) in 1st Edition of National Standard of Hospital Accreditation (SNARS  1st Edition)
Djoni Darmadjaja (SNARS  – INA)
1. Why is AMR control program included in SNARS?
2. What are the parameter of assessment?

09.45 –10.15

Basic Principles of Rational Antibiotic Use
Taralan Tambunan (INA)
Outline: AMU for prophylaxis and therapies

10.15 –10.30

Coffee Break

10.30 –11.15

Appropriate Microbiology Specimens Handling for Accurate Results
Ardiana Kusumaningrum (INA)
Outline: pre analytic of microbiology examination

11.15 – 12.00

Expert Rules of Antimicrobial Susceptibility Test Results
Dewi Anggraini (INA)
Outline: expert rules of AST based in CLSI and EUCAST

12.00 – 12.45

Pharmacokinetic and Pharmacodynamic of Antibiotics in Respiratory Tract Infection
Rianto Setiabudi (INA)
Outline: PK/PD of antibiotic for respiratory tract (oral and parenteral)

12.45 – 13.30


13.30 – 14.15

Clinical Implementation of Microbiological Test Results
Anis Karuniawati (INA)
1. interpretation of microb results
2. action taken base on result

14.15 – 15.00

Development of Antibiotic Use Guideline
Erlina Burhan (INA)

15.00 –15.45

Case Discussion 1:
Respiratory Tract Infection (Community-Acquired Pneumonia)
Linda Masniari (INA)

15.45 –16.00

Coffee Break

16.00 –16.45

Case Discussion 2:
Respiratory Tract Infection (Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia)
Pompini Agustina (INA)

16.45 –17.00

Post-test and closing
Dewi Anggraini (INA)